Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
November 27, 2020

Coronavirus company news summary – Biolidics inks deal to distribute Chinese biotech’s Covid-19 test kits – Alberta launches rapid testing pilot

By Chloe Kent

Salient Bio, a UK diagnostic firm, has launched the fastest robotics-driven Covid-19 mass testing platform, reports Pharma Phorum. The company claims that the platform can provide results with a 99% accuracy. There are different mass testing approaches, one being the breath test which has prompted the trial of the Microtox device. The UK is also conducting a mass trial programme at Liverpool, which has a surge in virus infections.

BASE10 Genetics and DNA Link have announced a collaboration to evaluate the use and efficacy of DNA Link’s AccuFind COVID-19 IgG antibody test in a point-of-care healthcare setting. Although Covid-19 cases and mortality rates have witnessed a recent surge in the US, many individuals have also recovered from the infection.

Biolidics Limited has entered into a deal with the Chinese biotech company, JOYSBIO, to develop and/or distribute the latter’s certified SARS-CoV-2 Antigen Rapid Test Kit. Under the terms of the agreement, Biolidics will distribute the kits worldwide for a period of one year from the date of the agreement.

Alberta Health Minister Tyler Shandro, the health minister has announced that the province is launching rapid Covid-19 tests in December to fast-track testing of all individuals showing Covid-19 symptoms and to track down everyone infected within the territory. Shandro stated that almost 100,000 PanBio and Abbott IDNow rapid-test kits were available for distribution and will be sent as a test pilot across the province to curb the spread of the disease.

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU